Stockscreener 앱 받기
1.59
6.71%
0.10
시간 외 거래:
1.50
-0.09
-5.66%
전일 마감가:
$1.49
열려 있는:
$1.49
하루 거래량:
85,700
Relative Volume:
0.35
시가총액:
$2.84M
수익:
$6.84M
순이익/손실:
$-21.84M
주가수익비율:
-0.000833
EPS:
-1908.5712
순현금흐름:
$-7.06M
1주 성능:
+12.77%
1개월 성능:
-0.31%
6개월 성능:
-70.14%
1년 성능:
-98.94%
1일 변동 폭
$1.45
$1.5999
1주일 범위
$1.36
$1.5999
52주 변동 폭
$1.265
$183.60
Invo Fertility Inc Stock (IVF) Company Profile
명칭
Invo Fertility Inc
전화
(978) 878-9505
주소
5582 BROADCAST COURT, SARASOTA
Compare IVF vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVF
Invo Fertility Inc
|
1.59 | 2.66M | 6.84M | -21.84M | -7.06M | -1,908.57 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Invo Fertility Inc 주식(IVF)의 최신 뉴스
IVF SEC FilingsINVO Fertility, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
INVO Fertility, Inc. 2025 10-K/A: Executive Compensation, Governance, and Financial Disclosures - Minichart
INVO Fertility (Nasdaq: IVF) updates 2025 10-K with pay, equity and restatement details - Stock Titan
INVO Fertility (IVF) Holds Gains, Faces Key Resistance Near $1.48Breakaway Gap - newsline.com
INVO Reverse Split: My Take On The 8-K Oklo Stock (Um5ahNsNst) - Fathom Journal
INVO Fertility Inc. (IVF) Q4 2025 Earnings: Significant EPS Miss Amidst Unreported RevenueEarnings Whisper Number - newsline.com
IVF Q3 2025 Earnings: Staggering EPS Miss Highlights Deep Financial DistressReturn On Capital - newsline.com
IVF Technical Analysis | Trend, Signals & Chart Patterns | INVO FERTILITY INC (NASDAQ:IVF) - ChartMill
INVO Fertility receives Nasdaq delisting notice for late filings By Investing.com - Investing.com Australia
INVO Bioscience Inc stock (US44984F1049): Nasdaq notice on late 10-Q filing and FY 2025 update - AD HOC NEWS
INVO Fertility receives Nasdaq delisting notice for late filings - Investing.com
INVO Fertility, Inc. Receives Nasdaq Delinquency Notice for Filing Violations - Quiver Quantitative
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
INVO Fertility, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
INVO Fertility, Inc. Files Form 8-K with NASDAQ Listing Details and Corporate Information – June 2026 - Minichart
INVO Fertility Reports 2025 Financial Results, Strengthens Balance Sheet, and Expands Clinic Network - Minichart
INVO Fertility to restate 2025 quarterly financials due to accounting errors By Investing.com - Investing.com India
INVO Fertility to restate 2025 quarterly financials due to accounting errors - Investing.com
INVO Fertility Announces Fiscal Year 2025 Financial Results - The Manila Times
INVO Fertility FY2025 revenue rises 5% on clinic acquisition - TradingView
INVO Fertility, Inc. FY 2025: Revenue $6.84M, EPS $(214.64) — 10-K Summary - TradingView
INVO Fertility: Revenue up 5% and net loss narrowed as four-clinic network and balance sheet strengthened - TradingView
INVO Fertility (IVF) 2025 revenue rises 5% as net loss widens sharply - Stock Titan
INVO Fertility To Restate Unaudited Financials For Q1, Q2, And Q3 2025SEC Filing - TradingView
INVO Fertility: Revenue rose 5% to $6.8M, but net loss from continuing operations was $5.3M in 2025 - TradingView
INVO Fertility (IVF) 10-K shows clinic growth but highlights going-concern risk - Stock Titan
INVO Fertility (NASDAQ: IVF) flags 2025 quarterly errors, plans restatement - Stock Titan
Press Release: INVO Fertility Announces Fiscal Year 2025 Financial Results - Moomoo
INVO Fertility, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
IVF Extends Volatile Rebound As Traders Eye Weak Fundamentals - timothysykes.com
INVO Fertility (IVF) Surges 10.6%: Technical Breakout or Temporary Rally?Inside Day Breakout - newsline.com
INVO Fertility up 14%; small IVF name faces filing risk - TechStock²
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
INVO Fertility (IVF) Gains 2.94% as Shares Approach Key Resistance LevelLast Point Resistance - The Legal Advocate
IVF Q3 2025 Earnings: EPS Misses Estimates by Wide Margin; Stock Rises $3.75Geographic Revenue Trends - The Legal Advocate
INVO Fertility Stock Slides After Filing Delay - Bez Kabli
INVO Fertility Inc. (IVF) Q3 2025 Earnings: Significant EPS Miss, No Revenue ReportedEarnings Forecast Report - The Legal Advocate
INVO Fertility Q3 2025 Earnings: Massive EPS Miss as Losses WidenRevenue Miss Report - Newser
INVO Bioscience Inc stock (US44984F1049): fertility player updates investors after financing move - AD HOC NEWS
INVO Fertility (IVF) Stock: Slides -6.55%, Support at $1.49 2026-05-21Put Support - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
INVO Fertility Discloses Delay In Quarterly Filing - TipRanks
INVO Fertility (IVF) files late‑filing notice after auditor change - Stock Titan
INVO Bioscience stock (US44984F1049): merger story, Nasdaq relisting and fertility-tech ambitions - AD HOC NEWS
Armistice Capital (NASDAQ: IVF) reports 9.99% ownership in INVO - Stock Titan
INVO Fertility Inc expected to post a loss of $2.75 a shareEarnings Preview - TradingView
Number of shareholders of INVO Fertility, Inc. – NASDAQ:IVF - TradingView
INVO Fertility (IVF) Stalls at $$1.57 — Consolidation Phase 2026-05-14Real Trader Network - newser.com
INVO Fertility, Inc (IVF) Eps Diluted (TTM) - Zacks Investment Research
The valuation case for INVO Fertility (IVF) that is hard to ignore (-4.23%) 2026-05-06Profit Potential - newser.com
Invo Fertility Inc (IVF) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.43%
자본화:
|
볼륨(24시간):